Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Debt to Equity: 2024-2025

Historic Debt to Equity for Editas Medicine (EDIT) over the last 1 years, with Sep 2025 value amounting to $4.39.

  • Editas Medicine's Debt to Equity was N/A to $4.39 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.39, marking a year-over-year change of. This contributed to the annual value of $0.43 for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Debt to Equity is $4.39, which was up 48.68% from $2.95 recorded in Q2 2025.
  • In the past 5 years, Editas Medicine's Debt to Equity ranged from a high of $4.39 in Q3 2025 and a low of $0.43 during Q4 2024.
  • Moreover, its 2-year median value for Debt to Equity was $1.91 (2025), whereas its average is $2.16.